Skip Navigation LinksPennsylvania Department of State > Professional Licensing > Boards & Commissions > Optometry > Announcements


Evidence-Based Prescribing:  Tools You Can Use to Fight the Opioid Epidemic (PDF)

Safe Prescribing of Opioids in Pediatric and Adolescent Populations (PDF)

Act 6 of 2018 Reporting of Sanctions and Criminal Proceedings, Suspension and Civil Penalties (PDF)

Fentanyl Safety Recommendations (PDF)

CHIP Provider Enrollment Information (PDF)

Drug Enforcement Administration (DEA) Renewal Change

Opioid Education for Optometrists Certified to Prescribe and Administer Pharmaceutical Agents and Renewals Submitted after July 1, 2017 (PDF)

aCT 31 OF 2014 



Department of Health Notice; Lifitegrast (Xiidra) ophthalmic solution (PDF)

Health Care Practitioner Photo Identification Badge Requirement (PDF)

Pennsylvania's New Prescription Drug Monitoring Program (PDF)

Naloxone Frequently Asked Questions (PDF)

Naloxone Prescription for Overdose Prevention (Standing Order DOH-002-2016) (PDF)

Naloxone for Opioid Safety - A Provider's Guide to Prescribing to Patients Who Use Opioids (PDF)

Naloxone Standing Order Prescription Letter for Pharmacists (PDF)

Veteran's Administration Hospitals-License Verification (PDF) 

American Board of Optometry (ABO) Board Certification (PDF) 

Drugs Approved for Use by Optometrists (PDF) 

DEA Rescheduling Hydrocodone Products (PDF)

Notice - Act 6 of 2018 Expungement Provisions (PDF)



Elder Financial Abuse Prevention (PDF)


<<Previous Page